CBDL Life Sciences Inc. (CBDL) in Final Stages
Post# of 103076
Life Sciences Inc. (CBDL) in Final Stages with Amazon
Press Release | 02/10/2021
SCOTTSDALE, AZ / ACCESSWIRE / February 10, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announces the company is in Final Stages with Amazon.
CBD Life Sciences Inc. is proud to announce that the company is in the Final Stages with getting its Hemp products on Amazon. The company decided to introduce the addition of its Hemp products on the shopping giant, Amazon.com, in a move that emphasizes the importance of hemp in the future of both LBC Bioscience Inc. and the nutritional hemp market which is "blowing up" around the world. The products we plan to distribute on Amazon focus more on the Health & Wellness side of things which would be our top selling Pain Relief Cream along with Anxiety and Sleep Tinctures.
Amazon is going to be greatly beneficial to CBD Life Sciences Inc and this is why: There are many Hemp Companies on Amazon but, President & CEO Lisa Nelson states "All of our products are Organic & Kosher, and that is one leverage we have over the competition. With that being said, we expect to gain explosive revenue in the upcoming months, and we couldn't be more excited to get the ball rolling!"
In 2021, Amazon is one of the top ways to grow your business and get your products in front of more people.
CBD Life Sciences Inc. has already identified several potential cultivation sites and is aggressively pursuing amazing new opportunities in Arizona's new recreational cannabis market. This new law gives CBD Life Sciences Inc. the capability to offer licensed retailers CBD Life Sciences Inc. premium cannabis products, which are then made available for sale to thousands of future recreational cannabis customers in addition to current cannabis sales to existing medical-use dispensaries in Arizona.